article thumbnail

Buprenorphine now replaces methadone as the most common medicine for opioid dependence’: 10-year trends in opioid agonist treatment medicines in Australia

National Drug & Alcohol Research Centre Blog

In Australia, both methadone and buprenorphine have been subsidised by the Pharmaceutical Benefit Scheme (PBS) for the treatment of opioid dependence (termed ‘opioid agonist treatment’ or OAT) for several decades. Our recent article, published in The International Journal of Drugs , presents the Australia-wide results. Chidwick, K.,

Treatment 133
article thumbnail

DrugBank adds ASHP data to knowledgebase, improving user experience and data reliability

DrugBank

ASHP’s full suite of drug information has been integrated into and made available through DrugBank, bringing together both company’s offerings to provide streamlined access to a broader range of high quality products.

article thumbnail

AHF Cheers Supreme Court ‘Rutledge’ Ruling Allowing States to Regulate PBMs

The Pharma Data

Pharmaceutical Care Management Association , the Court recognized that state legislatures have important powers to regulate abuses of corporate healthcare middlemen, called Pharmacy Benefit Managers (PBMs). (See This predatory practice has driven independent pharmacies out of business, to the harm of the patients they serve.”.